Vanda Pharmaceuticals Inc

NASDAQ:VNDA   3:59:59 PM EDT
14.31
-0.44 (-2.98%)
Products

Vanda Pharmaceuticals Settles Hetlioz Patent Litigation With MSN

Published: 01/14/2022 14:14 GMT
Vanda Pharmaceuticals Inc (VNDA) - Vanda Pharmaceuticals Settles Hetlioz® Patent Litigation With Msn.
Vanda Pharmaceuticals - Granted Msn and Impax Non-exclusive License to Manufacture & Commercialize Msn's Version of Hetlioz in U.S. Effective March 13, 2035.
Vanda Pharmaceuticals Inc - Msn and Impax May Enter Market Earlier Under Certain Limited Circumstances.
Vanda Pharmaceuticals Inc - Agreement Provides for a Full Settlement and Release by Vanda, Msn and Impax of All Claims.